Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:286-290

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwatsubo, H.
Right arrow Articles by Hata, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwatsubo, H.
Right arrow Articles by Hata, T.

(Hypertension. 1997;29:286.)
© 1997 American Heart Association, Inc.


Arthur C. Corcoran Memorial Lecture

Converting Enzyme Inhibitor Improves Forearm Reactive Hyperemia in Essential Hypertension

Haruhiko Iwatsubo; Masahiro Nagano; Tomoko Sakai; Kunihiko Kumamoto; Ryuhei Morita; Jitsuo Higaki; Toshio Ogihara; Takeshi Hata

From the Department of Cardiology, Higashiosaka Municipal Central Hospital (H.I., M.N., T.S., K.K., R.M., T.H.), and the Department of Geriatric Medicine, Osaka University Medical School (J.H., T.O.), Japan.

Correspondence to Masahiro Nagano, MD, Head of the Department of Cardiology Higashiosaka Municipal Central Hospital 2-3-1 Mikuriyaminami, Higashiosaka 577 Japan. E-mail nagano{at}geriat.med.osaka-u.ac.jp

Endothelial function is known to be impaired in essential hypertensive patients. In this study, we examined whether antihypertensive drugs improve forearm vasodilatory response to reactive hyperemia in 26 patients with essential hypertension (62±2 years) without diabetes mellitus, hyperlipidemia, coronary heart disease, or cerebrovascular disease. Antihypertensive drugs were never given or were discontinued for at least 4 weeks before the study. Patients were treated with monotherapy of either temocapril (2 or 4 mg, n= 15) or amlodipine (2.5 or 5 mg, n= 11) for 6 months. Forearm blood flow was measured by strain-gauge plethysmography. Vasodilator response to the release of upper arm compression at 300 mm Hg for 5 minutes and to sublingual administration of nitroglycerin (0.3 mg) were assessed. Changes of forearm blood flow response to reactive hyperemia were significantly less in hypertensive patients (99±18%) than in age-matched normotensive control subjects (150±22%, P<.01, n=39). Blood pressure (mm Hg) was similarly decreased by the treatment with temocapril (160±4/94±2 to 139±3/83±3, P<.001) or amlodipine (165±5/94±3 to 141±4/82±3, P<.001). Response to nitroglycerin was not changed by either drug. Forearm vasodilatory response to reactive hyperemia was improved by temocapril (102±20% to 168±25%, P<.01) but not by amlodipine (97±16% to 114±14%, NS). These results indicate that the treatment with the angiotensin-converting enzyme inhibitor temocapril improved forearm vasodilatory response to reactive hyperemia, suggesting its beneficial effect on endothelial function.


Key Words: amlodipine • antihypertensive drug • atherosclerosis • hyperemia • nitroglycerin • plethysmography • temocapril




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
R. M. de Albuquerque, C. E. Virgini-Magalhaes, F. Lencastre Sicuro, D. A. Bottino, and E. Bouskela
Effects of Cilostazol and Pentoxifylline on Forearm Reactive Hyperemia Response, Lipid Profile, Oxidative Stress, and Inflammatory Markers in Patients With Intermittent Claudication
Angiology, October 1, 2008; 59(5): 549 - 558.
[Abstract] [PDF]


Home page
Eur J Heart FailHome page
D. Tousoulis, C. Antoniades, C. Vassiliadou, M. Toutouza, C. Pitsavos, C. Tentolouris, A. Trikas, and C. Stefanadis
Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure
Eur J Heart Fail, December 1, 2005; 7(7): 1126 - 1132.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Fujiki, H. Shimokawa, K. Morikawa, H. Kubota, M. Hatanaka, M.A. H. Talukder, T. Matoba, A. Takeshita, and K. Sunagawa
Endothelium-Derived Hydrogen Peroxide Accounts for the Enhancing Effect of an Angiotensin-Converting Enzyme Inhibitor on Endothelium-Derived Hyperpolarizing Factor-Mediated Responses in Mice
Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): 766 - 771.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Tousoulis, C Antoniades, E Bosinakou, M Kotsopoulou, C Tsioufis, C Tentolouris, A Trikas, C Pitsavos, and C Stefanadis
Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure
Heart, January 1, 2005; 91(1): 27 - 31.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Vychytil, M. Fodinger, J. Pleiner, M. Mullner, P. Konner, S. Skoupy, C. Rohrer, M. Wolzt, and G. Sunder-Plassmann
Acute effect of amino acid peritoneal dialysis solution on vascular function
Am. J. Clinical Nutrition, November 1, 2003; 78(5): 1039 - 1045.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. Tousoulis, C. Antoniades, C. Tountas, E. Bosinakou, M. Kotsopoulou, P. Toutouzas, and C. Stefanadis
Vitamin C Affects Thrombosis/ Fibrinolysis System and Reactive Hyperemia in Patients With Type 2 Diabetes and Coronary Artery Disease
Diabetes Care, October 1, 2003; 26(10): 2749 - 2753.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Iuchi, M. Akaike, T. Mitsui, Y. Ohshima, Y. Shintani, H. Azuma, and T. Matsumoto
Glucocorticoid Excess Induces Superoxide Production in Vascular Endothelial Cells and Elicits Vascular Endothelial Dysfunction
Circ. Res., January 10, 2003; 92(1): 81 - 87.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
O. Stanger, H.-J. Semmelrock, W. Wonisch, U. Bos, E. Pabst, and T. C. Wascher
Effects of Folate Treatment and Homocysteine Lowering on Resistance Vessel Reactivity in Atherosclerotic Subjects
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 158 - 162.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. G. Modena, L. Bonetti, F. Coppi, F. Bursi, and R. Rossi
Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women
J. Am. Coll. Cardiol., August 7, 2002; 40(3): 505 - 510.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
Y. Higashi, S. Sasaki, K. Nakagawa, H. Matsuura, T. Oshima, and K. Chayama
Endothelial Function and Oxidative Stress in Renovascular Hypertension
N. Engl. J. Med., June 20, 2002; 346(25): 1954 - 1962.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Higashi, S. Sasaki, K. Nakagawa, M. Kimura, S. Sasaki, K. Noma, H. Matsuura, K. Hara, C. Goto, T. Oshima, et al.
Excess Norepinephrine Impairs Both Endothelium-Dependent and -Independent Vasodilation in Patients With Pheochromocytoma
Hypertension, February 1, 2002; 39(2): 513 - 518.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Imamura, S. Biro, T. Kihara, S. Yoshifuku, K. Takasaki, Y. Otsuji, S. Minagoe, Y. Toyama, and C. Tei
Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1083 - 1088.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Sanada, Y. Higashi, K. Nakagawa, S. Sasaki, I. Kodama, M. Tsuda, N. Nagai, and K. Ohama
Relationship between the angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women
J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1529 - 1535.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Higashi, S. Sasaki, K. Nakagawa, H. Matsuura, G. Kajiyama, and T. Oshima
Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 863 - 870.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. C. Kaski and L. F. Valenzuela Garcia
Therapeutic options for the management ofpatients with cardiac syndrome X
Eur. Heart J., February 2, 2001; 22(4): 283 - 293.
[PDF]


Home page
HypertensionHome page
K. Matsumoto, R. Morishita, A. Moriguchi, N. Tomita, M. Aoki, H. Sakonjo, K. Matsumoto, T. Nakamura, J. Higaki, and T. Ogihara
Inhibition of Neointima by Angiotensin-Converting Enzyme Inhibitor in Porcine Coronary Artery Balloon-Injury Model
Hypertension, February 1, 2001; 37(2): 270 - 274.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Higashi, S. Sasaki, K. Nakagawa, T. Ueda, A. Yoshimizu, S. Kurisu, H. Matsuura, G. Kajiyama, and T. Oshima
A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study
J. Am. Coll. Cardiol., February 1, 2000; 35(2): 284 - 291.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. J. Anderson, E. Elstein, H. Haber, and F. Charbonneau
Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)
J. Am. Coll. Cardiol., January 1, 2000; 35(1): 60 - 66.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Higashi, S. Sasaki, N. Sasaki, K. Nakagawa, T. Ueda, A. Yoshimizu, S. Kurisu, H. Matsuura, G. Kajiyama, and T. Oshima
Daily Aerobic Exercise Improves Reactive Hyperemia in Patients With Essential Hypertension
Hypertension, January 1, 1999; 33(1): 591 - 597.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Ishizuka, K. Konno, H. Naganuma, K. Nishimura, H. Kouzuki, H. Suzuki, B. Stieger, P. J. Meier, and Y. Sugiyama
Transport of Temocaprilat into Rat Hepatocytes: Role of Organic Anion Transporting Polypeptide
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 37 - 42.
[Abstract] [Full Text]


Home page
HypertensionHome page
Y. Higashi, T. Oshima, S. Sasaki, Y. Nakano, M. Kambe, H. Matsuura, and G. Kajiyama
Angiotensin-Converting Enzyme Inhibition, But Not Calcium Antagonism, Improves a Response of the Renal Vasculature to L-Arginine in Patients With Essential Hypertension
Hypertension, July 1, 1998; 32(1): 16 - 24.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Tomiyama, Y. Kimura, H. Mitsuhashi, T. Kinouchi, H. Yoshida, T. Kushiro, and N. Doba
Relationship Between Endothelial Function and Fibrinolysis in Early Hypertension
Hypertension, January 1, 1998; 31(1): 321 - 327.
[Abstract] [Full Text] [PDF]